Psychedelics show promise for treating depression, anxiety, and post-traumatic stress disorder – a 2020 study involving the American Psychiatric Association states.

At the same time, it says psychedelics are not yet ready for treatment. Even so, with moves to decriminalize these drugs in places like California, could they soon become more readily available?

In clinical treatment for depression, anxiety, and post-traumatic stress disorder (PTSD) could they help bring relief where other drugs haven’t worked?

In this Vital signs with Brendon Fallon, Dr. Bernardo Merizalde outlines the hope psychedelics offer for treatment and the dangers they pose if used without restraint.

Dr. Bernardo Merizalde is an assistant clinical professor at the Department of Psychiatry and Human Behavior, Thomas Jefferson University.

IG
https://www.instagram.com/see.vitalsigns/
Twitter
https://twitter.com/seevitalsigns

===================================================================================
Vital Signs’ host, guests and contributors offer general information on improving health and wellness. This is not intended as diagnosis or medical advice. You should consult your medical doctor or holistic doctor before enacting any suggested strategies for health and wellness improvement, including those in relation to preventing or treating specific diseases featured on this program.